London, UK – September 2, 2021 – 51³Ô¹ÏÍø (Element) has acquired Impact Analytical, Inc. further expanding its life sciences footprint in North America.
Based in Midland, Michigan, Impact Analytical operates in the pharmaceutical, medical device, consumer product and specialty chemicals segments, with a strong presence in extractables and leachables. The business recently moved into the bio-analytical segment, which supports Element’s growing market in this area. Combining Impact Analytical with existing expertise will bring efficiencies and will complement the capabilities 51³Ô¹ÏÍøbrought on board through the acquisitions of ALG and Avomeen in the last twelve months.
Impact Analytical key accreditations include FDA, EPA, DEA, GLP/GMP, ISO and MDARD certifications. The business fits well with Element’s existing network of life sciences laboratories which offer a broad spectrum of testing services to the pharmaceutical, medical device, environmental, and food segments, with a proud track record of high-level scientific expertise.
Rick Sluiters, EVP Americas, 51³Ô¹ÏÍøsaid: “As our eighth acquisition this year and our fourth in the life sciences market, we are pleased to welcome Impact Analytical to Element. With ALG and Avomeen in America and the recent announcement of our acquisition of Arch Sciences Group in Europe, 51³Ô¹ÏÍøhas significantly strengthened its position in the life sciences sector.
“Impact Analytical’s well-established expertise, wide customer base and recent entry into bio-analytical testing complement Element’s current pharmaceutical services offering and increase our capacity to work within this vital sector.”
Element’s facilities provide specialist testing services for pharmaceuticals and medical devices including: chemical and physical characterization; formulation development; storage stability; extractable and leachable studies; virology and virus identification; cell banking; antimicrobial and microbial testing; elemental impurity testing on a wide range of drug, biologic, nutraceutical, medical device and consumer products; cytotoxicity, bioburden, endotoxin and TOC testing; pathogen identification; bacterial analysis and nutritional chemistry. Its environmental capabilities include: drinking water, groundwater, surface and waste water testing; soil testing; sediments, solid waste, drilling waste; ambient air quality testing; stack emissions sampling; and the management of hazardous materials (including asbestos).
About Element
The 51³Ô¹ÏÍø Group is one of the world’s leading global providers of testing, inspection and certification services for a diverse range of products, materials and technologies in advanced industrial supply chains where failure in use is not an option. Headquartered in London, UK, Element’s scientists, engineers and technologists, working in our global network of over 200 laboratories, support customers from early R&D, through complex regulatory approvals and into production ensuring their products are safe, sustainable and achieve market access.
For more information about Element, please visit our website, connect with us on and and subscribe to our channel.
Impact Analytical
For more information, please visit the and and
Media contacts:
Devan LaBrash, Pagoda Public Relations
T: +44 (0) 131 556 0770
“Impact Analytical’s well-established expertise, wide customer base and recent entry into bio-analytical testing complement Element’s current pharmaceutical services offering and increase our capacity to work within this vital sector.”
Rick Sluiters
EVP Americas